RE: iqai2 Oct 2020 22:02
@IQAI_IB
Software being used to process data in another clinical trial - "Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed GBM". This randomized phase II/III trial studies how well temozolomide and veliparib work compared to temozolomide alone.
From twitter
from mayo clinic
This randomized phase II/III trial studies how well temozolomide and veliparib work and compare them to temozolomide alone in treating patients with newly diagnosed glioblastoma multiforme. Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Veliparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether temozolomide is more effective with or without veliparib in treating glioblastoma multiforme.